SciELO - Scientific Electronic Library Online

 
vol.11 número6SEUDOQUILOTÓRAX DE CAUSA NO DETERMINADA: REPORTE DE UN CASOLAS CONDICIONANTES HISTÓRICO SOCIALES AL PROBLEMA DE LA DISCAPACIDAD INFANTIL EN LA PROVINCIA DE CAMAGÜEY índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Archivo Médico de Camagüey

versión On-line ISSN 1025-0255

Resumen

ARREDONDO BRUCE, Alfredo  y  AMORES CARRATE, Jacqueline. Metabolic syndrome in current clinic. AMC [online]. 2007, vol.11, n.6. ISSN 1025-0255.

 A bibliographical revision about the metabolic syndrome is performed which is been considered a great factor since its description as X Syndrome in 1988, also known as insulin resistance syndrome, and nowadays as metabolic syndrome which is clinically recognized by abdominal obesity, elevated triglycerides, atherogenetic dyslipidemy, (low levels of lipoproteins of elevated density - cholesterol (HDL-C) high blood pressure, high glucose levels, and/or insulin resistance. This syndrome also is characterized by a prothrombotic and inflammatory state, affects approximately to the 24% of the adult population in the United States; according to the criteria of the Third National Health and Nutrition Examination Survey (NHANES III), near 47 million people have this syndrome. The pathogenesis is given by a complex of mutually interactive actions, between obesity and insulin resistance is presented since along  time ago in the pathogeny of the metabolic syndrome, the pathophysiology includes: insulin resistance, atherogenetic dyslipidemy, are also frequent prone particles to the oxidation as the chylomicrons of fast and postprandial and glycolysied LDL particles, hypertension, proinflammatory state, with an increase of the reactant acute phase (C-reactive protein CRP); and prothrombotic state, with an increase of the inhibitor activator of the plasminogen (PAI-1) and fibrinogen. 

Palabras clave : CEREBROVASCULAR DISORDERS [metabolism]; METABOLIC DISEASES; CARDIOVASCULAR DISEASES [metabolism].

        · resumen en Español     · texto en Español     · Español ( pdf )